Antitumor and anti-invasive effects of diverse new macrocyclic lactones, alkylolides and alkenylolides, and their enhancement by hyperthermia

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1257-1262

  Tanaka, Hiroshi ^a   Kageyama, Katsuhiro ^a   Kusumoto, Kumiko ^b   Asada, Ryoko ^a   Miwa, Nobuhiko ^c  

^a Osaka Butsuryo College   (Japan)

^b International Buddhist University   (Japan)

^c PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

Author keywords

Alkenylolide; Alkylolide; Antitumor activity; Hyperthermia; Marocyclic lactone; Tumor invasion

Indexed keywords

ANTINEOPLASTIC AGENT; BRYOSTATIN; BRYOSTATIN 1; LACTONE; MACROLIDE; RHIZOXIN;

ANIMAL; ARTICLE; CANCER INVASION; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; EHRLICH ASCITES TUMOR; FIBROSARCOMA; HUMAN; HYPERTHERMIC THERAPY; METABOLISM; MULTIMODALITY CANCER THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; BRYOSTATINS; CARCINOMA, EHRLICH TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; FIBROSARCOMA; HUMANS; HYPERTHERMIA, INDUCED; LACTONES; MACROLIDES; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED;

EID: 38449112384     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.5.1257     Document Type: Article

References (23)

1. Pettit GR, Herald CL, Doubek DL, Herald DL, Arnold E and Clardy J: Isolation and structure of bryostatin-1. J Am Chem Soc 104: 6846-6848, 1982.
2. Iwasaki S, Kobayashi H, Furukawa J, Namikoshi M, Okuda S, Sato Z, Matsuda I and Noda T: Studies on macrocyclic lactone antibiotics. VII. Structure of a phytotoxin 'Rhizoxin' produced by Rhizopus chinensis. J Antibiot 37: 354-362, 1984. (Pubitemid 14129486)
3. Kiyoto S, Kawai Y, Kawakita T, Kino E, Okuhara M, Uchida I, Kino E, Okuhara M, Uchida I, Tanaka H, Hashimoto M, Terano H and Kohsaka M: A new antitumor complex, WF-1360 A, B, C, D, E and F. J Antibiot 39: 762-772, 1986.
4. Gebbia V, Citarrella P, Miserendino V, Valenza R, Borsellino N, Pesta A, Pettit R and May S: The effects of the macrocyclic lactone bryostatin-1 on leukemic cells in vitro . Tumori 30: 167-171, 1992.
5. Schuchter LM, Esa AH, May S, Laulis MK, Pettit GR and Hess AD: Successful treatment of murine melanoma with bryostatin-1. Cancer Res 51: 682-687, 1991.
6. Harris M: Criteria of viability in heat-treated cells. Expt Cell Res 44: 658-660, 1966.
7. Palzer RJ and Heidelberger C: Studies on the quantitative biology of hyperthermic killing of HeLa cells. Cancer Res 33: 415-421, 1973.
8. Kageyama K, Onoyama Y, Otani S, Kimura M, Matsui-Yuasa I, Nagao N and Miwa N: Promotive action of acylated ascorbate on cellular DNA synthesis and growth at low doses in contrast to inhibitory action at high doses or upon combination with hyperthermia. J Cancer Res Clin Oncol 122: 41-44, 1996.
9. Ishiyama M, Shiga M, Sakamoto K, Mizoguchi M and Pin-Gang He: A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem Pharm Bull 41: 1118-1122, 1993.
10. Kusumoto K, Kageyama K, Tanaka H, Kogawa H and Miwa N: Enhancement of carcinostatic activity of omega-hydroxy fatty acids by their esterification through increased uptake into tumor cells. Oncol Rep 11: 857-861, 2004.
11. Gray JG, Monaco AP, Wood ML and Russell PS: Study on Heterologeus anti-lymphocyte serum in mice. J Immunol 96: 217-228, 1966.
12. Anderson TF: Techniques for the preservation of threedimensional structure in preparing specimens for the electron microscopes. Trans NY Acad Sci 13: 130-134, 1951.
13. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitatating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987. (Pubitemid 17082655)
14. Kageyama K, Onoyama Y, Nakanishi M, Matsui-Yuasa I, Otani S and Morisawa S: Synergistic inhibition of DNA synthesis in Ehrlich ascites tumour cells by a combination of unsaturated fatty acids and hyperthermia. J Appl Toxcol 9: 1-4, 1989. (Pubitemid 19058282)
15. Takada Y, Kageyama K, Yamada R, Onoyama Y, Nakajima T, Hosono M and Miwa N: Correlation of DNA synthesis-inhibiting activity and the transmembrane permeation into tumor cells by unsaturated or saturated fatty alcohols of graded chain-lenghth upon hyperthermia. Oncol Rep 8: 547-551, 2001. (Pubitemid 33758452)
16. De Lorenzo MS, Yamaguchi K, Subbaramaiah K and Dannenberg AJ: Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism. Clin Cancer Res 9: 5036-5043, 2003. (Pubitemid 37323311)
17. Kraft AS, Smith JB and Berkow RL: Bryostatin, an activator of the calcium phospholipid-dependent protein kinase blocks phorbol ester-induced differenciation human promyelocytic leukemia cells HL-60. Proc Natl Acad Sci USA 83: 1334-1338, 1986. (Pubitemid 16016123)
18. Takahashi M, Iwasaki S, Kobayashi H, Okuda S, Murai T and Sato Y: Rhizoxin binding to tubulin at the maytansine-binding site. Biochem Biophys Acta 926: 215-223, 1987. (Pubitemid 18016164)
19. Kageyama K, Yamada R, Otani S, Onoyama Y, Yano I, Yamaguchi W, Yamaguchi Y, Kogawa H, Nagao N and Miwa N: Cytotoxicity of docosahexaenoic acid and eicosajpentaenoic acid in tumor cells and the dependence on binding to serum proteins and incorporation into intracellular lipids. Oncol Rep 7: 79-83, 2000.
20. Mondovi B, Finazzi AA, Rotillo G, Strom R, Moricca G and Rossi FA: The biochemical mechanism of selective heat sensitivity of cancer cells. II. Studies on nucleic acids and protein synthesis. Eur J Cancer 5: 137-146, 1969.
21. Henle KJ and Leeper DB: Effect of hyperthermia (45°C) on macromolecular synthesis in Chinese hamster ovary cells. Cancer Res 39: 2665-2674, 1979. (Pubitemid 9204210)
22. Kageyama K, Onoyama Y, Kimura M, Yamazaki H and Miwa N: Enhanced inhibition of DNA synthesis and release of membrane phospholipids in tumour cells treated with a combination of acylated asorbate and hyperthermia. Int J Hyperthermia 7: 85-91, 1991.
23. Tanaka H, Kageyama K, Yoshimura N, Asada R, Kusumoto K and Miwa N: Anti-tumor and anti-invasive effects of diverse delta-alkyllactone: Dependence on molecular side-chain length, action period and intracellular uptake. Life Sciences 80: 851-855, 2007.